Literature DB >> 2843055

Serotonergic mechanisms mediate renal sympathoinhibition during severe hemorrhage in rats.

D A Morgan1, P Thoren, E A Wilczynski, R G Victor, A L Mark.   

Abstract

Hemorrhage in rats produces reflex decreases in heart rate (HR) and renal sympathetic nerve activity (RSNA). Because serotonergic antagonists attenuate hemorrhage-induced vagal-mediated bradycardia, we determined whether blockade of serotonin synthesis by p-chlorophenylalanine (PCPA) or of serotonin receptors with methysergide would also abolish the renal sympathoinhibition. Mean arterial pressure (MAP), HR, and RSNA were recorded in chloralose-anesthetized rats pretreated with PCPA (300 mg.kg-1.day-1 X 3 days ip, n = 12) or vehicle (0.3 ml saline, n = 9). During hemorrhage, where MAP was maintained at 50 mmHg for 8 min, vehicle-treated rats decreased HR by 27 +/- 13 beats/min and RSNA by -55 +/- 7%. In PCPA-treated rats, HR and RSNA did not change. Cervical vagotomy abolished the bradycardia and sympathoinhibition during hemorrhage. After acute administration of methysergide (400 micrograms/kg iv, n = 8) hemorrhage produced increases of RSNA, whereas vehicle (0.5 ml saline, n = 7) preserved the renal sympathoinhibition to hemorrhage in conscious rats. Finally, volume expansion (0.88 ml blood/100 g body wt) produced comparable decreases in RSNA in sinoaortic-denervated rats pretreated with PCPA (n = 11) or vehicle (n = 10) (-58 +/- 9 vs. 47 +/- 7%, respectively). We conclude that serotonergic mechanisms are critically involved in vagal afferent inhibition of RSNA during severe hemorrhage in rats.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843055     DOI: 10.1152/ajpheart.1988.255.3.H496

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

Review 1.  The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances.

Authors:  B P Grubb; B J Karas
Journal:  J Interv Card Electrophysiol       Date:  1998-12       Impact factor: 1.900

2.  Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension.

Authors:  R L Converse; T N Jacobsen; C M Jost; R D Toto; P A Grayburn; T M Obregon; F Fouad-Tarazi; R G Victor
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

Review 3.  Preventable deaths after injury: why are the traditional 'vital' signs poor indicators of blood loss?

Authors:  R A Little; E Kirkman; P Driscoll; J Hanson; K Mackway-Jones
Journal:  J Accid Emerg Med       Date:  1995-03

Review 4.  Typical vasovagal syncope as a "defense mechanism" for the heart by contrasting sympathetic overactivity.

Authors:  Paolo Alboni; Marco Alboni
Journal:  Clin Auton Res       Date:  2017-07-01       Impact factor: 4.435

5.  Arterial diameter during central volume depletion in humans.

Authors:  H K Iversen; P Madsen; S Matzen; N H Secher
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

6.  Short-term regulation of Na+/K+ adenosine triphosphatase by recombinant human serotonin 5-HT1A receptor expressed in HeLa cells.

Authors:  J P Middleton; J R Raymond; A R Whorton; V W Dennis
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

7.  Effects of sertraline on autonomic and cognitive functions in healthy volunteers.

Authors:  Martin Siepmann; Jens Grossmann; Michael Mück-Weymann; Wilhelm Kirch
Journal:  Psychopharmacology (Berl)       Date:  2003-04-12       Impact factor: 4.530

Review 8.  Neurally mediated syncope and serotonin reuptake inhibitors.

Authors:  D Samoil; B P Grubb
Journal:  Clin Auton Res       Date:  1995-10       Impact factor: 4.435

Review 9.  Vasovagal Syncope As A Manifestation Of An Evolutionary Selected Trait.

Authors:  Paolo Alboni; Marco Alboni
Journal:  J Atr Fibrillation       Date:  2014-08-31

10.  Baroreflex responses to the stress of severe hemorrhage in the rat.

Authors:  W C Randall; T Kroeker; K Hotmire; T Burkholder; S Huprich; K Firth
Journal:  Integr Physiol Behav Sci       Date:  1992 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.